High-dose influenza vaccine shows no additional benefit for heart disease patients

Robert S. Hays

News Release

Friday, December 4, 2020

NIH-funded study finds increased dose is not much more helpful at minimizing significant flu troubles in this large-danger team.

High-dose influenza (generally recognised as flu) vaccines are no superior than normal-dose influenza vaccines in lowering deaths and hospitalizations between patients with fundamental heart disorder, in accordance to a significant examine publishing in JAMA. The outcomes do not alter properly-recognized findings about the benefit of an annual influenza vaccine for people with coronary heart disease and other serious ailments, and do not change the suggestion for an yearly influenza vaccine for most men and women. 

The analyze was funded by the Nationwide Heart, Lung, and Blood Institute (NHLBI), aspect of the National Institutes of Well being, and seems on the net on December 4.

“Getting a vaccine is even additional essential than typical this year, as men and women with COVID-19 who get the flu are at higher hazard for more serious complications,” reported Lawton S. Cooper, M.D., M.P.H., one of the study’s co-authors and a researcher with the Clinical Programs and Prevention Branch, Division of Cardiovascular Sciences, NHLBI. “People must comply with the advice of their health care supplier as to which flu vaccine, higher or very low dose, is much better for them, but having the flu shot is a lot more important than which dose.”

Scientists have recognised for some time that men and women with cardiovascular sickness are at greater hazard for building major difficulties from influenza, such as heart assaults, hospitalizations for coronary heart failure, and loss of life. As a consequence, industry experts have strongly advised that this team get an influenza vaccine, and at least one examine has suggested that a large-dose edition might help reduce these difficulties additional than the regular-dose vaccine.

To figure out if there is reward in the increased dose, the NHLBI funded the Influenza Vaccine to Properly Stop Cardio Thoracic Situations and Decompensated heart failure (INVESTED) demo, a randomized, double-blind trial carried out at 157 health-related facilities in the United States and Canada more than three influenza seasons. The demo, which was introduced in September 2016, incorporated a overall of 5,260 patients who had been just lately hospitalized for a cardiovascular occasion, such as coronary heart attack inside the prior year or coronary heart failure within the preceding two many years.

Each individual participant also experienced 1 or far more further threat things for cardiovascular disease—for case in point, they were being age 65 or more mature, smoked, or had variety 2 diabetic issues, being overweight, kidney sickness, peripheral artery disorder, or a history of stroke.

At the conclude of the review, the composite full of hospitalizations and fatalities was around equivalent for both flu vaccine teams. The researchers noticed 883 hospitalizations due to cardiovascular or pulmonary leads to and 92 deaths from any lead to in the significant-dose vaccine team, while they saw 846 hospitalizations for these activities and 78 fatalities from any bring about in the frequent-dose vaccine team. The big difference was not statistically important.

Orly Vardeny, Pharm.D., M.S., lead researcher of the review and associate professor of drugs at the University of Minnesota’s Health care University and School of Pharmacy, Minneapolis, reported there are a few of doable explanations for the conclusions. “First, we enrolled men and women at significant possibility for coronary heart and lung-linked hospitalizations,” she stated, “so it’s achievable that the incremental benefit of one particular vaccine more than the other would not have prevail over the large underlying threat in this populace.” Whilst there had been many hospitalizations for the duration of the trial, only a tiny number ended up recognized as brought on by influenza, thus one more likelihood is that since all individuals received the influenza vaccine, equally the superior- and very low-dose formulas equally lessened their chance for coronary heart and lung hospitalizations, Vardeny discussed.

Even though there ended up few vaccine-relevant aspect effects in either team, clients who acquired significant-dose vaccines tended to have more regular injection-related aspect consequences, these types of as discomfort, swelling, and muscle aches.

“It’s crucial to keep in mind that all members in INVESTED received a vaccination, and that both equally vaccine formulations ended up generally nicely tolerated with quite handful of clients enduring severe adverse reactions, with no difference between groups,” mentioned Scott Solomon, M.D., analyze co-leader and professor of drugs at Harvard Clinical College. “Unfortunately, a lot of large-danger cardiovascular patients don’t get vaccinated at all. For cutting down hospitalizations thanks to coronary heart and lung problems, just getting vaccinated with any influenza vaccine may possibly substantially lessen hazard in our high-threat patients.”

The researchers pointed out caveats in the review, like its target on individuals with a higher hazard for cardiovascular disease, use of vaccine formulations out there through the 2016-17, 2017-18, and 2018-19 influenza seasons, and use of vaccines that ended up ready in rooster eggs. The scientists explained upcoming studies should really analyze no matter if other types of flu vaccine may perhaps be far more protecting for people with higher-possibility disorders or whether a significant-dose vaccine benefits lower-hazard cardiac sufferers extra.

This examine is supported by grants from the NHLBI (U01HL130163 and U01HL130204).

EDITOR’S Notice: The Countrywide Influenza Vaccination Week, observed from December 6-12, highlights the great importance of influenza vaccination.

About the Countrywide Heart, Lung, and Blood Institute (NHLBI): NHLBI is the world wide chief in conducting and supporting investigation in heart, lung, and blood disorders and slumber diseases that advancements scientific knowledge, enhances community wellbeing, and will save life. For more information and facts, visit 

About the Countrywide Institutes of Overall health (NIH):&#13
NIH, the nation’s clinical investigation agency, involves 27 Institutes and Centers and is a ingredient of the U.S. Office of Well being and Human Expert services. NIH is the most important federal company conducting and supporting essential, clinical, and translational clinical analysis, and is investigating the brings about, treatments, and cures for the two typical and rare ailments. For additional data about NIH and its programs, pay a visit to www.nih.gov.

NIH…Turning Discovery Into Health®


Influence of higher-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with higher-risk cardiovascular condition: a randomized clinical demo.” DOI: 10.1001/jama.2020.23649.


Next Post

Q&A for Consumers | Hand Sanitizers and COVID-19

En Español The FDA is working with U.S. government partners including the Centers for Disease Control and Prevention (CDC), medical product manufacturers, and international partners to address the coronavirus disease 2019 (COVID-19) outbreak. Find the most recent FDA updates on our Coronavirus Disease 2019 page. Test your knowledge about hand […]

Subscribe US Now